PMS43 COST-UTILITY AND MULTINOMIAL EXPECTED VALUE OF PERFECT INFORMATION OF SEQUENCED TREATMENT WITH BIOLOGICS IN MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS- ANALYSIS BASED ON CLINICALLY MEANINGFUL RESPONSES
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72196-9
https://www.valueinhealthjournal.com/article/S1098-3015(11)72196-9/fulltext
Title :
PMS43 COST-UTILITY AND MULTINOMIAL EXPECTED VALUE OF PERFECT INFORMATION OF SEQUENCED TREATMENT WITH BIOLOGICS IN MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS- ANALYSIS BASED ON CLINICALLY MEANINGFUL RESPONSES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72196-9&doi=10.1016/S1098-3015(11)72196-9
First page :
A310
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
354